| 摘要 |
The invention relates to a method of treating or preventing multiple sclerosis in an animal subject using one or more neural regeneration peptides (NRPs). In particular, the invention relates to the use of NRP 2945 and closely related analogues for treating or preventing multiple sclerosis or seizures in an animal subject. More particularly, the invention relates to the use of NRP 2945 and closely related analogues to prevent the axonal damage or demyelination of central nervous system cells. |
